We aim to determine the accuracy and specificity of Arterial spin labeling (ASL) — a non‐invasive perfusion technique used in MRI to track cerebral blood flow — in measuring vascular and glial‐dependent water transfer to establish whether it is a valuable clinical tool in Alzheimer’s disease. This simple and safe technique, already approved for use in a clinical setting, has potential to circumvent current invasive approaches in human subjects at risk for AD‐related dementias.
May 1, 2020 — May 1, 2021
Garvey Institute for Brain Health Solutions
Seattle, University of Washington
Cognitive Disorders, PTSD, Traumatic Brain Injury (TBI)